v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash $ 1,174,280
Prepaid expenses 52,807 40,000
Prepaid insurance 60,312
Total Current Assets 1,287,399 40,000
Deferred offering costs 351,275
Prepaid insurance – long term 38,054
Investments held in Trust Account 232,871,546
Total Assets 234,196,999 391,275
Current Liabilities    
Accounts payable and accrued expenses 18,000 33,875
Accrued offering costs 75,000 307,325
Total Current Liabilities 93,000 465,990
Deferred legal fee 104,231
Deferred underwriting fee payable 8,050,000
Total Liabilities 8,247,231 465,990
Commitments and Contingencies (Note 6)
Shareholders’ Deficit:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding at June 30, 2026 and December 31, 2025
Additional paid-in capital 24,233
Accumulated deficit (6,922,615) (99,715)
Total Shareholders’ Deficit (6,921,778) (74,715)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit 234,196,999 391,275
Related party    
Current Liabilities    
Promissory note – related party 124,790
Class A Ordinary Shares    
Current Liabilities    
Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 and no shares at redemption value of $10.12 and $0 per share at June 30, 2026 and December 31, 2025, respectively 232,871,546
Shareholders’ Deficit:    
Ordinary shares, value 70
Class B Ordinary Shares    
Shareholders’ Deficit:    
Ordinary shares, value [1] $ 767 $ 767
[1] Includes up to 1,000,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. In December 2025, the Company issued additional 1,916,667 founder shares through a share capitalization resulting in the Sponsor holding 7,666,667 founder shares in the aggregate. All share and per-share data have been retrospectively presented (see Note 5 and Note 7). On February 20, 2026, the underwriters exercised their over-allotment option in full and was settled as part of the closing of the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over-allotment option, 1,000,000 founder shares are no longer subject to forfeiture by the Sponsor (see Note 7).